which glp 1 are approved for weight loss The first ever FDA-approved GLP-1 pill loss. Now on Ro. For Important Safety Information about GLP-1 medications, including Boxed Warning, go to ro.co/safety #wegovy #glp1 Compare GLP-1 Options | Ozempic

Sleep difficulty: Positioning and congestion may disturb sleep

Cold medication stings more

Tirzepatide is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment Lightheadedness occurs through reduced fluid intake from gastrointestinal effects, blood pressure lowering from weight loss, or hypoglycaemia when combined with insulin or sulfonylureas Seek immediate medical attention for loss of consciousness, chest pain, severe confusion, or persistent vomiting preventing fluid intake Management includes maintaining adequate hydration (6-8 glasses daily), eating regular small meals, rising gradually from sitting or lying positions, and medication review with your GP Report frequent or concerning lightheadedness to your healthcare team within 24 hours for dose adjustment or investigation of alternative causes Table of Contents Why Mounjaro Can Cause Lightheadedness Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus

Table 4 provides a summary of these warnings and precautions that are noted in the prescribing information for these products